Savara (SVRA) Capital Expenditures (2009 - 2026)
Savara (SVRA) recorded Capital Expenditures of $222,000 in Q2 2026, compared with $15,000 a year earlier and up 311.1% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Capital Expenditures (2009 - 2026) Analysis & Trends
On a TTM basis, Savara's Capital Expenditures came in at $280,000 as of Jun 30, 2026; for FY2025, it was $22,000, down 12.0% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $25,000 in FY2024 (-91.6%), $296,000 in FY2023, $9,000 in FY2022 (-84.2%) and $57,000 in FY2021 (+21.3%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q2 2023.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 975.0% in Q3 2023, against a decline of 93.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $54,000 (Q1 2026), $2,000 (Q4 2025) and $2,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Savara | 1.09 Bn | 407.27 Mn | - | 353,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 353,000.00 |
| Jun 30, 2026 | 222,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 18,000.00 |
API Access
Savara Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();